Cargando…
Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection
BACKGROUND: Approaches to limiting exposure to antiretroviral therapy (ART) drugs are an active area of HIV therapy research. Here we present longitudinal follow-up of a randomized, open-label, single-center study of the immune, viral, and safety outcomes of structured therapy interruptions (TIs) in...
Autores principales: | Papasavvas, Emmanouil, Kostman, Jay R, Mounzer, Karam, Grant, Robert M, Gross, Robert, Gallo, Cele, Azzoni, Livio, Foulkes, Andrea, Thiel, Brian, Pistilli, Maxwell, Mackiewicz, Agnieszka, Shull, Jane, Montaner, Luis J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539050/ https://www.ncbi.nlm.nih.gov/pubmed/15630469 http://dx.doi.org/10.1371/journal.pmed.0010064 |
Ejemplares similares
-
Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
por: Giron, Leila B., et al.
Publicado: (2021) -
Interferon-α alters host glycosylation machinery during treated HIV infection
por: Giron, Leila B., et al.
Publicado: (2020) -
Metabolic and anthropometric parameters contribute to ART-mediated CD4(+ )T cell recovery in HIV-1-infected individuals: an observational study
por: Azzoni, Livio, et al.
Publicado: (2011) -
A Correlate of HIV-1 Control Consisting of Both Innate and Adaptive Immune Parameters Best Predicts Viral Load by Multivariable Analysis in HIV-1 Infected Viremic Controllers and Chronically-Infected Non-Controllers
por: Tomescu, Costin, et al.
Publicado: (2014) -
Randomized Trial of Time-Limited Interruptions of Protease Inhibitor-Based Antiretroviral Therapy (ART) vs. Continuous Therapy for HIV-1 Infection
por: Firnhaber, Cynthia, et al.
Publicado: (2011)